市場調査レポート

欧州の末梢血管ステント市場

European Markets for Peripheral Vascular Stents

発行 Medtech Insight 商品コード 220550
出版日 ページ情報 英文 151 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
欧州の末梢血管ステント市場 European Markets for Peripheral Vascular Stents
出版日: 2011年10月28日 ページ情報: 英文 151 Pages
概要

2010年、欧州の末梢血管ステントは4億3,700万米ドルの売上をあげました。同市場は今後も9%の成長率で伸び続け、2014年には6億1,900万米ドルに達するとみられています。

当レポートは、欧州末梢血管ステント市場における製品概要と技術動向、現在および将来の市場動向、競合企業と市場の機会などをまとめ、概略下記の構成でお届けいたします。

エグゼクティブサマリー

第1章 現在および新興の末梢血管および非血管ステント技術

  • ステントのデザイン
    • 血管ステント
    • 非血管ステント
    • ステント導入メカニズム
  • ステントの材料
    • メタルステント
    • 標準ポリマーステント
    • 生分解性ポリマーステント
  • ステントコーティング
    • 放射線不透過性
    • 生物適合性
    • 能動的治療
  • ステントのカバーリングとライニング

第2章 末梢血管用ステントの応用動向

  • 心血管疾患
    • 発生率と有病率
  • 末梢血管疾患
    • 末梢動脈疾患
      • 末梢動脈疾患
      • 下肢動脈疾患
      • 腎動脈狭窄
      • 動脈瘤
    • 末梢静脈疾患
      • 慢性静脈不全
      • 静脈血栓症
    • 原因
      • 動脈硬化
      • 高血圧
      • 糖尿病
    • 外科的介入

第3章 欧州の末梢血管ステント市場

  • 腸骨動脈ステント
  • 大腿膝窩動脈ステント
  • 経頸静脈性肝内門脈体循環短絡術
  • 腎動脈ステント
  • 腹部大動脈瘤ステントグラフト
  • 頸動脈ステント
  • 統合市場分析
    • 製品と技術
    • 市場分析
    • 競合分析

第4章 企業プロファイル

  • Abbott Laboratories
  • C.R. Bard, Inc.
  • Boston Scientific Corporation
  • Cook Group, Inc.
  • ev3, Inc./Covidien, Inc.
  • W.L. Gore & Associates, Inc.
  • Johnson & Johnson
  • Medtronic, Inc.
目次
Product Code: A252

Abstract

First introduced in the early 1990s as a bailout technique for suboptimal or failed iliac angioplasty, peripheral vascular stenting gradually emerged as a valuable and versatile tool for a variety of primary and adjuvant applications within noncoronary vasculature. In 2010, peripheral vascular stents were used in more than 148,300 interventional procedures (including iliac artery stenting, fem-pop stenting, TIPS procedures, renal artery stenting, endovascular AAA repair, and carotid artery stenting) in the European countries covered by this report (France, Germany, Italy, Spain, and the United Kingdom) generating an estimated $437 million in corresponding product sales. Over the forecast period covered by this report, the number of peripheral vascular stenting procedures performed in Europe is expected to increase at 5% growth rate, reaching nearly 181,200 in the year 2014; during the same period, corresponding dollar sales are expected to increase at a 9% growth rate, reaching approximately $619 million in the year 2014.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European peripheral vascular stents market. Major topics covered by this report include a discussion of current and emerging peripheral vascular stenting technologies; a clinical overview of peripheral vascular conditions targeted by stenting, and an analysis of the European markets for iliac artery stents, fem-pop stents, TIPS devices, renal artery stents, AAA repair stent-grafts, and carotid artery stents.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

Table of Contents

EXECUTIVE SUMMARY

  • i. Stent Design
  • ii. Procedure Volumes
  • iii. Market Analysis
    • a. Iliac Artery Stents
    • b. Femoropopliteal Stents
    • c. Transjugular Intrahepatic Portosystemic Shunts
    • d. Renal Artery Stents
    • e. Endovascular Abdominal Aortic Aneurysm Repair Stent-Grafts
    • f. Carotid Artery Stents
  • Exhibit ES-1: Europe, Peripheral Vascular Stenting, Combined Procedure Volumes Forecast, 2010-2014
  • Exhibit ES-2: Europe, Peripheral Vascular Stents, Combined Market Forecast, 2010-2014

1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES

  • 1.1 Stent Design
    • 1.1.1 Vascular Stents
    • 1.1.2 Nonvascular Stents
    • 1.1.3 Stent Deployment Mechanisms
  • 1.2 Stent Materials
    • 1.2.1 Metal Stents
      • 1.2.1.1 Absorbable Magnesium Alloys
      • 1.2.1.2 Cobalt Alloys
      • 1.2.1.3 Nickel-Titanium Alloys
      • 1.2.1.4 Stainless Steel
    • 1.2.2 Standard Polymeric Stents
    • 1.2.3 Biodegradable Polymeric Stents
  • 1.3 Stent Coatings
    • 1.3.1 Radiopacity Enhancement
    • 1.3.2 Biocompatibility Enhancement
    • 1.3.3 Active Therapeutic Enhancement
      • 1.3.3.1 Drug-Eluting Stents
        • 1.3.3.1.1 Antirestenotic Drug-Eluting Stents
        • 1.3.3.1.2 Drug Delivery Techniques
    • 1.3.4 Stent Coverings and Linings
  • Exhibit 1-1: Selected Biomedical, Clinical, and Technical Stent Requirements
  • Exhibit 1-2: Advantages and Disadvantages of Selected Vascular Stent Designs
  • Exhibit 1-3: Advantages and Disadvantages of Metal Stent Materials
  • Exhibit 1-4: Selected Polymeric Stent Materials
  • Exhibit 1-5: Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents
  • Exhibit 1-6: Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers for Drug-Eluting Stents

2. OVERVIEW OF STENTING FOR PERIPHERAL VASCULAR APPLICATIONS

  • 2.1 Cardiovascular Disease
    • 2.1.1 Incidence and Prevalence
  • 2.2 Peripheral Vascular Disease
    • 2.2.1 Peripheral Artery Disease
      • 2.2.1.1 Carotid Artery Disease
      • 2.2.1.2 Lower Extremity Peripheral Artery Disease
      • 2.2.1.3 Mesenteric Artery Disease
    • 2.2.1.4Renal Artery Stenosis
      • 2.2.1.5 Aneurysm
        • 2.2.1.5.1 Abdominal Aortic Aneurysm
      • 2.2.1.6 Other Types of Peripheral Artery Disease
    • 2.2.2 Peripheral Venous Disorders
      • 2.2.2.1 Chronic Venous Insufficiency
      • 2.2.2.2 Thrombophlebitis
      • 2.2.2.3 Varicose Veins
    • 2.2.3 Causes
      • 2.2.3.1 Atherosclerosis
        • 2.2.3.1.1 Incidence and Prevalence
        • 2.2.3.1.2 Treatment
      • 2.2.3.2 Hypertension
        • 2.2.3.2.1 Incidence and Prevalence
        • 2.2.3.2.2 Treatment
      • 2.2.3.3 Diabetes
        • 2.2.3.3.1 Type 1 Diabetes
        • 2.2.3.3.2 Type 2 Diabetes
        • 2.2.3.3.3 Macrovascular Disease
        • 2.2.3.3.4 Hyperglycemia and Atherosclerosis
        • 2.2.3.3.5 Hyperinsulinemia and Atherosclerosis
        • 2.2.3.3.6 Incidence and Prevalence
        • 2.2.3.3.7 Treatment
    • 2.2.4 Surgical Intervention
      • 2.2.4.1 Ablative Laser-Assisted Angioplasty
      • 2.2.4.2 Bypass Grafting
      • 2.2.4.3 Catheter-Based Thrombolysis and Mechanical Thrombectomy
      • 2.2.4.4 Cryo-Balloon Angioplasty
      • 2.2.4.5 Endarterectomy
      • 2.2.4.6 Percutaneous Transluminal Angioplasty
      • 2.2.4.7 Peripheral Atherectomy
      • 2.2.4.8 Vascular Brachytherapy
      • 2.2.4.9 Intravascular Stenting
        • 2.2.4.9.1 Drug-Eluting Stents
  • Exhibit 2-1: 2008, Europe, Cardiovascular Disease-Related Deaths, by Country
  • Exhibit 2-2: The Peripheral Arteries
  • Exhibit 2-3: Arteries of the Head and Neck
  • Exhibit 2-4: Arteries of the Lower Body
  • Exhibit 2-5: Classification of Abdominal Aortic Aneurysms
  • Exhibit 2-6: 2008, Europe, Deaths Due to Ischemic Heart Disease, by Age
  • Exhibit 2-7: 2004, Systolic Blood Pressure Levels in Selected European Countries
  • Exhibit 2-8: 2010, Europe, Diabetes Prevalence, by Country

3. EUROPEAN PERIPHERAL VASCULAR STENTS MARKET

  • 3.1 Iliac Artery Stents
    • 3.1.1 Products and Technologies
    • 3.1.2 Market Analysis
    • 3.1.3 Competitive Analysis
  • 3.2 Femoropopliteal Stents
    • 3.2.1 Products and Technologies
    • 3.2.2 Market Analysis
    • 3.2.3 Competitive Analysis
  • 3.3 Transjugular Intrahepatic Portosystemic Shunts
    • 3.3.1 Products and Technologies
    • 3.3.2 Market Analysis
    • 3.3.3 Competitive Analysis
  • 3.4 Renal Artery Stents
    • 3.4.1 Products and Technologies
    • 3.4.2 Market Analysis
    • 3.4.3 Competitive Analysis
  • 3.5 Endovascular Abdominal Aortic Aneurysm Repair Stent-Grafts
    • 3.5.1 Products and Technologies
    • 3.5.2 Market Analysis
    • 3.5.3 Competitive Analysis
  • 3.6 Carotid Artery Stents
    • 3.6.1 Products and Technologies
    • 3.6.2 Market Analysis
    • 3.6.3 Competitive Analysis
  • 3.7 Combined Market Analysis
    • 3.7.1 Market Drivers
    • 3.7.2 Market Limiters
    • 3.7.3 Market Forecast
  • Exhibit 3-1: 2011, Selected Iliac Artery Stents
  • Exhibit 3-2: Europe, Iliac Artery Stenting, Procedure Volumes Forecast, 2010-2014
  • Exhibit 3-3: Europe, Iliac Artery Stents, Market Forecast, 2010-2014
  • Exhibit 3-4: 2010, Europe, Iliac Artery Stents Market, Share by Supplier
  • Exhibit 3-5: 2011, Selected Femoropopliteal Stents
  • Exhibit 3-6: Europe, Femoropopliteal Stenting, Procedure Volumes Forecast, 2010-2014
  • Exhibit 3-7: Europe, Femoropopliteal Stents, Market Forecast, 2010-2014
  • Exhibit 3-8: 2010, Europe, Femoropopliteal Stents Market, Share by Supplier
  • Exhibit 3-9: 2011, Selected Transjugular Intrahepatic Portosystemic Shunts
  • Exhibit 3-10: Europe, Transjugular Intrahepatic Portosystemic Shunting, Procedure Volumes Forecast, 2010-2014
  • Exhibit 3-11: Europe, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2010-2014
  • Exhibit 3-12: 2010, Europe, Transjugular Intrahepatic Portosystemic Shunts Market, Share by Supplier
  • Exhibit 3-13: 2011, Selected Renal Artery Stents
  • Exhibit 3-14: Europe, Renal Artery Stenting, Procedure Volumes Forecast, 2010-2014
  • Exhibit 3-15: Europe, Renal Artery Stents, Market Forecast, 2010-2014
  • Exhibit 3-16: 2010, Europe, Renal Artery Stents Market, Share by Supplier
  • Exhibit 3-17: 2011, Selected Endovascular Abdominal Aortic Aneurysm Stent-Grafts
  • Exhibit 3-18: Europe, Endovascular Abdominal Aortic Aneurysm Stent-Graft Repair, Procedure Volumes Forecast, 2010-2014
  • Exhibit 3-19: Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2010-2014
  • Exhibit 3-20: 2010, Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts Market, Share by Supplier
  • Exhibit 3-21: 2011, Selected Carotid Artery Stents
  • Exhibit 3-22: Europe, Carotid Artery Stenting, Procedure Volumes Forecast, 2010-2014
  • Exhibit 3-23: Europe, Carotid Artery Stents, Market Forecast, 2010-2014
  • Exhibit 3-24: 2010, Europe, Carotid Artery Stents Market, Share by Supplier
  • Exhibit 3-25: Europe, Peripheral Vascular Stents, Combined Market Forecast, 2010-2014

4. COMPANY PROFILES

  • 4.1 Abbott Laboratories
  • 4.2 C.R. Bard, Inc.
  • 4.3 Boston Scientific Corporation
  • 4.4 Cook Group, Inc.
  • 4.5 ev3, Inc./Covidien, Inc.
  • 4.6 W.L. Gore & Associates, Inc.
  • 4.7 Johnson & Johnson
  • 4.8 Medtronic, Inc.
Back to Top